Locations:

Research

December 5, 2017/Cancer/Research

The Impact of Multigene Panel Testing on Surgical Decisions for Breast Cancer Patients

Finding variants of uncertain significance does not increase the rate of contralateral prophylactic mastectomies

November 20, 2017/Cancer/Research

New Sickle Cell Disease Treatment Shows Positive Results in Phase 1 Clinical Trial

Novel drug could greatly improve patient outcomes

October 24, 2017/Cancer/Research

The Breast Microbiome

Links between bacterial composition and breast cancer

October 23, 2017/Cancer/Research

TLR4: The Key to Cancer Stem Cell Evasion of Immune Suppression?

Glioblastoma CSCs express less TLR4

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

September 27, 2017/Cancer/Research

Targeted Therapies + SRS Combo Prolongs Survival in Patients with Renal Cell Carcinoma Brain Metastases

But the combination increases toxicity risks

September 27, 2017/Cancer/Research

A Pan-Cancer Encyclopedia of Genetic Variants Causing Radiation Resistance

ASTRO 2017 abstract finds radiosensitivity variants

September 27, 2017/Cancer/Research

Beyond Pack-Years: Assessing & Treating HPV+ Oropharynx Cancer

20 pack-years better indicator of high-risk disease

September 26, 2017/Cancer/Research

Analysis of Treatment Plans Suggests Guidelines Impractical for Planning with IG-VMAT for Oropharynx Cancer

Opportunity for more nuanced approach

September 25, 2017/Cancer/Research

Novel, Targeted Therapies for Patients with Advanced, RET-Positive NSCLC

Lenvatinib promising, trials ongoing

September 24, 2017/Cancer/Research

Single Fraction SBRT Appropriate for Long-Term Use in Inoperable Early Stage NSCLC

Data confirm original clinical trial results

BackPage 24 of 27Next